Topics
Glioblastoma | Treatment | Clinical trials | 5-Aminolevulinic Acid
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > 5-Aminolevulinic Acid
Cozzens JW, Lokaitis BC, Delfino K, Hoeft A, Moore BE, Fifer AS,
Amin DV, Espinosa JA, Jones BA, Acakpo-Satchivi L.
A
Phase 2 Sensitivity and Selectivity
Study of High-Dose 5-Aminolevulinic
Acid in Adult Patients Undergoing Resection
of a Newly Diagnosed or Recurrent
Glioblastoma.
Oper
Neurosurg (Hagerstown). 2024 Nov 11. doi:
10.1227/ons.0000000000001417. PMID:
39526779. Interventional study˰
ˍ